Stay updated on Ipatasertib Combo in Metastatic Prostate Cancer Clinical Trial
Sign up to get notified when there's something new on the Ipatasertib Combo in Metastatic Prostate Cancer Clinical Trial page.

Latest updates to the Ipatasertib Combo in Metastatic Prostate Cancer Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedRevision: v3.4.2 was added to the history. The older operating-status notice (v3.4.1) was removed.SummaryDifference0.4%

- Check22 days agoChange DetectedAdded a site-wide notice about government funding and status updates with links to cc.nih.gov and opm.gov, and updated the revision from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check29 days agoChange DetectedThe Record History page now includes a glossary toggle, color-coded change highlights (green for additions, red for deletions), and explicit revision notes (e.g., Revision: v3.4.0) to aid understanding of history changes.SummaryDifference0.5%

- Check36 days agoChange DetectedAdded Revision: v3.3.4 to the history list. Removed Revision: v3.3.3 from the history list.SummaryDifference0.1%

- Check65 days agoChange DetectedAdded Revision: v3.3.3 to the Record History; removed HHS Vulnerability Disclosure and Revision: v3.3.2 from the footer.SummaryDifference0.1%

- Check86 days agoChange DetectedRevision: v3.3.2 is now shown in the page history, replacing v3.3.1. This update does not alter any study records or displayed information on the page.SummaryDifference0.1%

Stay in the know with updates to Ipatasertib Combo in Metastatic Prostate Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ipatasertib Combo in Metastatic Prostate Cancer Clinical Trial page.